![Garry Nolan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Garry Nolan
Gründer bei
Nodality, Inc.
Profil
Garry P.
Nolan is the founder of Nodality, Inc. founded in 2005, serving as Director since 2009.
Dr. Nolan is the founder of Bina Technologies, Inc. founded in 2012.
Dr. Nolan is the founder of Parhelia Biosciences Corp.
founded in 2019.
Dr. Nolan is the founder of Rigel Pharmaceuticals, Inc. founded in 1995.
Dr. Nolan was the founder of Akoya Biosciences, Inc. founded in 2015, served as Independent Director from 2015 to 2025.
Dr. Nolan is also the founder of IONpath, Inc.,DVS Sciences, Inc...
Dr. Nolan is Director at National Heart, Lung & Blood Institute.
Dr. Nolan is Professor-Microbiology & Immunology at Stanford University School of Medicine.
Dr. Nolan is Senior Advisor at Arsenal Capital Management LP.
Dr. Nolan was Trustee at Leukemia Society of America, Inc. in 1998.
Dr. Nolan earned a doctorate from Stanford University in 1989.
Dr. Nolan earned an undergraduate degree from Cornell University in 1983.
Aktive Positionen von Garry Nolan
| Unternehmen | Position | Beginn |
|---|---|---|
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Develops bioinformatics tools to enhance drug development process | Gründer | 01.03.2005 |
National Heart, Lung & Blood Institute
 National Heart, Lung & Blood Institute General GovernmentGovernment Promotes the prevention and treatment of heart, lung and blood diseases | Direktor/Vorstandsmitglied | - |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Arsenal Capital Management LP
 Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital invests in middle market companies located in the United States. The firm focuses on healthcare and industrial sectors. It participates in buyouts, add-on acquisitions and growth stage capital transactions. | Berater | - |
Ehemalige bekannte Positionen von Garry Nolan
| Unternehmen | Position | Ende |
|---|---|---|
| AKOYA BIOSCIENCES, INC. | Gründer | 08.07.2025 |
Bina Technologies, Inc.
 Bina Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides platform accelerating and genomic analysis services | Gründer | 02.03.2015 |
| RIGEL PHARMACEUTICALS, INC. | Gründer | 02.03.2001 |
Leukemia Society of America, Inc. | Direktor/Vorstandsmitglied | 01.01.1998 |
Ausbildung von Garry Nolan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
81
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Rigel Pharmaceuticals, Inc.
 Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
Nodality, Inc.
Nodality, Inc. BiotechnologyHealth Technology Develops bioinformatics tools to enhance drug development process | Health Technology |
DVS Sciences, Inc.
 DVS Sciences, Inc. Medical DistributorsDistribution Services Develops analytical equipment and reagent for CyTOF instrument | Distribution Services |
Bina Technologies, Inc.
Bina Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides platform accelerating and genomic analysis services | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arsenal Capital Management LP
Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital invests in middle market companies located in the United States. The firm focuses on healthcare and industrial sectors. It participates in buyouts, add-on acquisitions and growth stage capital transactions. | Finance |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Heart, Lung & Blood Institute
National Heart, Lung & Blood Institute General GovernmentGovernment Promotes the prevention and treatment of heart, lung and blood diseases | Government |
Leukemia Society of America, Inc. | |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IONpath, Inc.
 IONpath, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company specializing in high-definition spatial proteomics | Health Technology |
Akoya Biosciences, Inc.
 Akoya Biosciences, Inc. BiotechnologyHealth Technology Develops a novel high-parameter tissue analysis platform | Health Technology |
